Skip to content

Efficacy and safety of different modalities in the treatment of seborrheic keratosis

A comparative study of efficacy and safety of cryosurgery, electrocoagulation, CO2 laser and Erbium:YAG laser in the treatment of seborrheic keratoses

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141228020468N5
Enrollment
32
Registered
2019-09-11
Start date
2019-04-21
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seborrheic keratosis. Seborrheic keratosis

Interventions

Intervention 1: Control group 1: Electrodessication with the same parameters on seborrheic keratosis lesions. The electrodessication (electrosurgical unit, MEG1, Iran Kavandish System co, made in Iran
Laseroptek Co., Ltd., Sungnam, Gyenggido, Korea). We applied the energy of 500 MJ, with a spot size of 4 mm. All lesions were treated in one session and they received the same amount of energy, fluenc
Hironic Co., Ltd, Korea). We applied the energy of 1.5 J / cm2, pulse duration of 0.4 sec and spot size of 4 mm. All lesions were treated in one session and they received the same amount of energy, f

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: Age 35 to 85 All participants should have at least 4 seborrheic keratoses with similar size and thickness on face

Exclusion criteria

Exclusion criteria: History of keloid History of coagulopathy or anticoagulant treatment Uncontrolled diabetes Uncontrolled hypertension Active infection on face Non-compliance with treatment and follow ups History of autoimmune connective tissue disease Known allergy to lidocaine or tetracaine Cold intolerance Cryoglobulinemia Cold urticaria and any kind of cold rash

Design outcomes

Primary

MeasureTime frame
The rate of recovery of seborrheic keratosis. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Photography before procedure and in follow up intervals, patient satisfaction.

Secondary

MeasureTime frame
Pain. Timepoint: Immediately after the intervention and 2, 8 weeks after the intervention. Method of measurement: Asking the patients.;Dyspigmentation. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Scar. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Keloid formation. Timepoint: Before the intervention and 2, 8 weeks after the intervention. Method of measurement: Evaluation of patients photographs by two dermatologists.;Infection. Timepoint: 2, 8 weeks after the intervention. Method of measurement: Asking the patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Zaresharifi

Shahid Beheshti University of Medical Sciences

shirin.zsharifi@sbmu.ac.ir+98 21 2243 9982

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026